Peptide record

TPDB06823

Halictine 2 Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06823
Halictine 2
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF pep-lab AFP-GFuse Antifungipept CAFPdb APD_complete APD_hemolytic Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 12-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GKWMSLLKHILK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C69H116N18O14S1
ARNDCEQFPTYV
LK
1453.85
10.84
4
0
6
+3
-0.05
0.067
130.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
5500
3.78
1
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
1
G
1
H
1
I
3
L
3
K
1
M
0
F
0
P
1
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 1 I: 1 L: 3 K: 3 M: 1 F: 0 P: 0 S: 1 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
12 reviewed residue count
C69H116N18O14S1 sequence-only estimate (linear, free termini)
1453.85 sequence-only estimate (linear, free termini)
10.84 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-0.05 sequence-only estimate (linear, free termini)
0.067 sequence-only estimate (linear, free termini)
Free Activity
L Activity
Not Available Activity
Free Activity
Anticancer Activity
Venom, the eusocial bee, Halictus sexcinctus Activity
Evidence Records 16 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.8-7.7 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Highly active against B. subtilis, S. aureus, E. coli (MIC 0.8-7.7 uM) and moderately active against P. aeruginosa (MIC ~45 uM). Also active against C. albicans
Evidence 2 Activity

Activity

MIC
Antibacterial
6-7 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

0.8-7.7 uM) and moderately active against P. aeruginosa (MIC ~45 uM). Also active against C. albicans (MIC 6-7 uM) as well as cancer cells such as Hela S3, CRC SW480, and CCRF-CEMT IC50 12-35 uM (Slaninov
Evidence 3 Activity

Activity

Not Available
Anticancer

Target

Not Available
Not Available
Not Available

Assay & Model

Not Available
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2010

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 4 Activity

Activity

MIC
Antifungal
0.8-7.7 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Highly active against B. subtilis, S. aureus, E. coli (MIC 0.8-7.7 uM) and moderately active against P. aeruginosa (MIC ~45 uM). Also active against C. albicans
Evidence 5 Activity

Activity

MIC
Antifungal
6-7 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

0.8-7.7 uM) and moderately active against P. aeruginosa (MIC ~45 uM). Also active against C. albicans (MIC 6-7 uM) as well as cancer cells such as Hela S3, CRC SW480, and CCRF-CEMT IC50 12-35 uM (Slaninov
Evidence 6 Activity

Activity

MIC
Antiparasitic
0.8-7.7 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Highly active against B. subtilis, S. aureus, E. coli (MIC 0.8-7.7 uM) and moderately active against P. aeruginosa (MIC ~45 uM). Also active against C. albicans
Evidence 7 Activity

Activity

MIC
Antiparasitic
6-7 µM

Target

Candida albicans

Source & Reference

DRAMP

Other

0.8-7.7 uM) and moderately active against P. aeruginosa (MIC ~45 uM). Also active against C. albicans (MIC 6-7 uM) as well as cancer cells such as Hela S3, CRC SW480, and CCRF-CEMT IC50 12-35 uM (Slaninov
Evidence 8 Activity

Activity

MIC
Antiviral
0.8-7.7 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Highly active against B. subtilis, S. aureus, E. coli (MIC 0.8-7.7 uM) and moderately active against P. aeruginosa (MIC ~45 uM). Also active against C. albicans
Evidence 9 Activity

Activity

MIC
Antiviral
6-7 µM

Target

Candida albicans

Source & Reference

DRAMP

Other

0.8-7.7 uM) and moderately active against P. aeruginosa (MIC ~45 uM). Also active against C. albicans (MIC 6-7 uM) as well as cancer cells such as Hela S3, CRC SW480, and CCRF-CEMT IC50 12-35 uM (Slaninov
Evidence 10 Activity

Activity

LC50
Hemolysis
78.1 µM
[Ref.20198492] LC50=78.1µM against rat red blood cells

Target

rat red blood cells

Source & Reference

Hemolytik APD_complete APD_hemolytic PD_Hemolysis
DRAMP4
Amino Acids. 2010 Aug 39(3):763-75.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 11 Activity

Activity

50% Hemolysis
Toxicity
78.1 µM
Hemolytic Cytotoxic
50% Hemolysis | 78.1 | µM | target cell: Rat erythrocytes

Target

Rat erythrocytes

Source & Reference

NA
DBAASP
Evidence 12 Activity

Activity

IC50
Toxicity
23±9 µM
Cytotoxic
IC50 | 23±9 | µM | target cell: Human umbilical vein endothelial cells HUVEC

Target

Human umbilical vein endothelial cells HUVEC

Source & Reference

NA
DBAASP
Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells. | Peptides | 2012
Evidence 13 Activity

Activity

IC50
Toxicity
40±5 µM
Cytotoxic
IC50 | 40±5 | µM | target cell: Rat epithelial cells IEC-6, CRL-1592

Target

Rat epithelial cells IEC-6, CRL-1592

Source & Reference

NA
DBAASP
Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells. | Peptides | 2012
Evidence 14 Activity

Activity

50% Hemolysis
Toxicity
78 µM
Hemolytic Cytotoxic
50% Hemolysis | 78 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antifungal activity of analogues of antimicrobial peptides isolated from bee venoms against vulvovaginal Candida spp. | FEMS Yeast Res | 2019
Evidence 15 Activity

Activity

LC50
Toxicity
78.1 µM
Hemolytic
Hemolytic_activity: [Ref.20198492] LC50=78.1µM against rat red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Amino Acids. 2010 Aug 39(3):763-75.
Evidence 16 Hemolysis

Activity

78.1 µM
LC50
[Ref.20198492] LC50=78.1µM against rat red blood cells
Hemolysis

Target

rat red blood cells

Source & Reference

APD_complete APD_hemolytic PD_Hemolysis
Amino Acids. 2010 Aug 39(3):763-75.
DRAMP4
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.